Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 1 of the 13 calendar months from Oct 2025 to Oct 2026: Nov 2025.
- Largest single sale: $2.7M (18,000 shares) of Neurocrine Biosciences Inc on Nov 5, 2025. Filing
- Last sale before this period: May 5, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Neurocrine Biosciences Inc (NBIX) | Director | Feb 8, 2010 | May 29, 2026 |
| Illumina, Inc. (ILMN) | Former Director | May 21, 2004 | Jan 4, 2016 |
| Biogen (BIIB) | Former Executive Chairman, Director | Feb 10, 2004 | Jul 1, 2005 |
Also a director at
Illumina, Inc. (ILMN) (no filing in the last 18 months), Biogen (BIIB) (no filing in the last 18 months)
Recent filings
The last 2 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.